I
iovera
Biotech & Life Sciences · Fremont, United States · Founded 2005
MyoScience develops and commercializes technology-driven dermatological products MoreLess
Myoscience operates in the medical technology sector, specializing in cryoanalgesia solutions designed to provide immediate and long-lasting non-opioid pain relief. The company's core product is a handheld device that targets both superficial and deep nerves, making it suitable for various clinical settings. Myoscience primarily serves healthcare providers, including doctors and clinics, who incorporate their technology into pain management practices. The business model revolves around selling these advanced medical devices and offering comprehensive support and resources to healthcare professionals for effective implementation. Revenue is generated through direct sales of the devices and potentially through service agreements for ongoing support and training.
Keywords: cryoanalgesia, non-opioid, pain relief, handheld device, medical technology, healthcare providers, nerve targeting, clinical settings, pain management, innovative solutions.
Company overview
iovera company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2005
- Headquarters
- Fremont, United States
- Employees
- 23
- Open positions
- None listed
- Dealroom signal
- 37.6
Valuation & funding
iovera funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| FundingOther financing | Jun 2026 | $70M | — | Zimmer Biomet | ↗ |
| ACQUISITIONOther financing | Mar 2019 | $220M | $220M | Pacira Biosciences | — |
| EARLY VCOther financing | Mar 2018 | $10M | $40M | Valiance Asset Management · Accuitive Medical Ventures | — |
| LATE VCOther financing | Oct 2017 | $14M | $56M | Undisclosed | — |
| SERIES EOther financing | Sep 2013 | $25M | $100M | Saratoga Ventures · DeNovo Ventures · Accuitive Medical Ventures · Medicis Capital | — |
| SERIES DOther financing | Mar 2012 | DeNovo Ventures · Accuitive Medical Ventures · Nexus Medical Partners · Saratoga Ventures | — | ||
| SERIES COther financing | Mar 2011 | Undisclosed | — | ||
| SERIES BOther financing | Jul 2008 | Saratoga Ventures · Nexus Medical Partners · DeNovo Ventures · Accuitive Medical Ventures | — | ||
| SERIES AOther financing | Jan 2007 | Undisclosed | — |
Growth signals
iovera website traffic
Latest recorded traffic for iovera is 5.3K monthly website visits. iovera's team declined 14.8% over the past year.
Comparisons
iovera compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
iovera's talent
Source: Dealroom Talent Intelligence.
Investors
8 investors on iovera's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where iovera has talent and traffic
In the news
Latest news about iovera
Recent press, funding announcements, and product moves mentioning iovera — open to read from the original sources.
Market sentiment
What the market is saying about iovera
An AI-synthesized read of the highest-engagement posts about iovera on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See iovera’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.